Top news of the day across the health care landscape.
A novel method of inactivating hepatitis C virus in donor lungs could increase transplantations for patients with end stage lung disease.
The ability to automate a medical benefit investigation is bringing new efficiencies to the hub and delivering better outcomes for providers, patients, and manufacturers.
Researchers have determined that many potentially adverse effects are not present on fact-based health care reviews.
Top news of the day across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
Sofosbuvir-based regimens for the treatment of hepatitis C were well tolerated in Asian American communities, according to a new study.

Most Popular

Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.